Richard C Turkington

8PUBLICATIONS
34CO-AUTHORS
Predictive and prognostic markersCancer geneticsMedical infection agents (incl. prions)Molecular targetsInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jan 04, 2026
Prognostic significance of beta-adrenergic receptor expression in oesophageal adenocarcinoma.

Talita Oliveira, Swathi Sasi, James Trainor

|Sep 14, 2025
Research priorities for cancers of the oesophagus and stomach: recommendations from a UK and Ireland patient and healthcare professional partnership exercise.

Christopher M Jones, Wee Han Ng, Laura Tincknell

|Jul 27, 2023
Pathologic Lymph Node Regression After Neoadjuvant Chemotherapy Predicts Recurrence and Survival in Esophageal Adenocarcinoma: A Multicenter Study in the United Kingdom.

Jonathan L Moore, Michael Green, Aida Santaolalla

|Jan 05, 2023
Mismatch Repair and Microsatellite Instability Testing for Immune Checkpoint Inhibitor Therapy: ASCO Endorsement of College of American Pathologists Guideline.

Praveen Vikas, Hans Messersmith, Carolyn Compton

|Aug 12, 2022
Identification of Src as a Therapeutic Target in Oesophageal Adenocarcinoma through Functional Genomic and High-Throughput Drug Screening Approaches.

Niamh H McCabe, Leanne Stevenson, Enya Scanlon

|Jan 22, 2021
Immune cell infiltrates as prognostic biomarkers in pancreatic ductal adenocarcinoma: a systematic review and meta-analysis.

Andrew J McGuigan, Helen G Coleman, R Stephen McCain

Pageof 2

Frequent Collaborators

2 joint publications

Andrew McGuigan

2 joint publications

Rebecca C Fitzgerald

1 joint publications

Helen G Coleman

1 joint publications

R Stephen McCain